Medication availability, formulations, pricing, and treatment recommendations may change based on pharmacy supply, regulatory requirements, and individual patient needs
Many pharmacies have pharmacists available to assess specific exposure scenarios and advise whether the medication is still suitable for use
Continued bloodwork to monitor AMH, FSH, and estradiol is essential to optimizing the dose
Store in a well-closed container away from moisture and direct sunlight
It targets both GIP and GLP-1 receptors simultaneously
Marketed under the brand name Mounjaro in the UK, it represents a new addition to incretin-based therapies, offering a dual mechanism that distinguishes it from existing GLP-1 receptor agonists such as semaglutide or dulaglutide